In healthy humans, TCA infused in the rectum stimulate GLP-1 and PYY secretion [211], while in patients with type 2 diabetes, and healthy control, intragastric infusion of CDCA is associated with increased GLP-1 and glucagon levels [212]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.